Christoph Oster

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Newly Diagnosed

Prognostic Factors

Top Venues

Nature communications

Journal of clinical immunology

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Hanah Hadice Gull, Antonia Carlotta Von Riegen, Greta Theresa Beckmann, Pikria Ketelauri, Sebastian Walbrodt, Alejandro N Santos, Christoph Oster, Teresa Schmidt, Martin Glas, Ramazan Jabbarli, Neriman Özkan, Philipp Dammann, Björn Scheffler, Ulrich Sure, Yahya Ahmadipour
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients. Cancers 16 (6) (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Hanah Hadice Gull, Antonia Carlotta Von Riegen, Greta Theresa Beckmann, Pikria Ketelauri, Sebastian Walbrodt, Alejandro N Santos, Christoph Oster, Teresa Schmidt, Martin Glas, Ramazan Jabbarli, Neriman Özkan, Philipp Dammann, Björn Scheffler, Ulrich Sure, Yahya Ahmadipour
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients. Cancers 16 (6) (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Jonas Feldheim, Almuth F Kessler, Julia J Feldheim, Dominik Schmitt, Christoph Oster, Lazaros Lazaridis, Martin Glas, Ralf-Ingo Ernestus, Camelia M Monoranu, Mario Löhr, Carsten Hagemann
BRMS1 in Gliomas-An Expression Analysis. Cancers 15 (11) (2023)
Christoph Oster, Benjamin Stolte, Livia Asan, Refik Pul, Stephan Klebe, Martin Köhrmann, Katharina Breuckmann, Christoph Rischpler, Cornelius Deuschl, Sebastian Dolff, Christoph Kleinschnitz, Tim Hagenacker
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report. Journal of clinical immunology (2023)
Jonas Alexander Feldheim, Teresa Schmidt, Christoph Oster, Julia Feldheim, Martin Stuschke, Walter Stummer, Oliver Grauer, Björn Scheffler, Carsten Hagemann, Ulrich Sure, Christoph Kleinschnitz, Lazaros Lazaridis, Sied Kebir, Martin Glas
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic. Cancers 15 (16) (2023)
Christoph Oster, Teresa Schmidt, Sarina Agkatsev, Lazaros Lazaridis, Christoph Kleinschnitz, Ulrich Sure, Björn Scheffler, Sied Kebir, Martin Glas
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022. Neuro-oncology advances 5 (1) (2023)